Rouet, F., Foulongne, V., Viljoen, J., Steegen, K., Becquart, P., Valéa, D., Danaviah, S., Segondy, M., Verhofstede, C., Van de Perre, P. and for the WHO/ANRS 1289 Kesho Bora Study Group (2010) Comparison of the Generic HIV Viral Load® Assay with AmplicorTM HIV-1 Monitoring v1.5 and Nuclisens HIV-1 EasyQ® v1.2 Techniques for Plasma HIV-1 RNA Quantification of Non-B Subtypes: The Kesho Bora Preparatory Study. Journal of Virological Methods, 163, 253-257.
http://dx.doi.org/10.1016/j.jviromet.2009.10.005

has been cited by the following article:

• TITLE: Comparison of an In-House Quantitative Real-Time PCR and COBAS AmpliPrep/TaqMan Roche for Determination of Viral Load for HIV Type 1 Non-B

  AUTHORS: Erick Ntambwe Kamangu, Adawaye Chatte, Raphael Boreux, Fabrice Susin, Richard Lunganza Kalala, Georges Lelo Mvumbi, Patrick De Mol, Marie-Pierre Hayette, Dolores Vaira

  KEYWORDS: COBAS AmpliPrep/TaqMan, In-House PCR Assays, HIV-1 Non-B

  JOURNAL NAME: Open Access Library Journal, Vol.2 No.3, March 20, 2015

  ABSTRACT: Context: The in-house techniques or experimental methods are increasingly recommended for their low-cost reagents for the determination of the Viral Load (VL) in resource-limited settings. The objective of this study was to compare the determination of VL from HIV-1 non-B samples by an in-house technique with the COBAS AmpliPrep/TaqMan version 2.0. Method: In this cross-sectional study, 39 plasma samples from patients infected with HIV type 1 non-B from N’Djamena and Kinshasa were used to determine the VL using the two techniques. Results: The mean values of VL are respectively 4.68 ± 1.26 and 4.58 ± 1.33 log10 RNA copies/ml for the COBAS AmpliPrep/TaqMan assays and the in-house assays. A good correlation (Spearman Correlation) was obtained, with a coefficient (R2) of 0.9452. Conclusion: This study demonstrates that there is no significant difference between the results of VL determined by the COBAS AmpliPrep/TaqMan assays and the in-house assays used.